<DOC>
	<DOC>NCT01441336</DOC>
	<brief_summary>Although laparoscopic gastrectomy (LG) is widely used for the treatment of early gastric cancer, there have been few reports of the efficacy of LAG in the management of advanced gastric cancer(AGC). The aim of this study is to evaluate the surgical outcomes and oncologic safety of laparoscopic gastrectomy for AGC.</brief_summary>
	<brief_title>Laparoscopic Gastrectomy for Advanced Gastric Cancer</brief_title>
	<detailed_description>Prospective phase II clinical trial to evaluate technical and oncological safety of LG for AGC LG procedure for AGC: D2 lymphadenectomy Total omentectomy for tumor with serosa exposure under laparoscopic exploration Primary end point: 3 year disease free survival secondary end point: postoperative outcomes, morbidity and mortality, 3,5 and 7 year overall survival, Quality of life, recurrence pattern Study duration: 7 years(enrollment: 4year, follow-up: 3year)</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>Age 2080 informed consent no other malignancies cT2N0cT3N2 according to JGCA 2nd edition ASA score&lt;3 distant metastasis(P1 or M1) under laparoscopic exploration Conglomerated N2 early gastric cancer in permanent pathologic report</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>